Delivery Order SPE2DB22D1017-SPE2DB24FG3AD

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,770.74 and an ultimate completion date of November 5, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $9,058.66, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of March 5, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,047.03 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 24, 2025, with a completion date of February 25, 2025. This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,228.50 firm fixed price delivery order contract has a performance period ending on May 23, 2025. The prime contractor is AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set aside and was awarded as a delivery order...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,097.08, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of March 12, 2024. This award is a delivery order under Amerisourcebergen's...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,770.74 firm fixed-price contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $18,395.16, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of October 29, 2024. The contract is not designated as a set-aside and appears to be part of a larger...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,150.31 and a completion date of October 25, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $10,702.96, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2025. It is a delivery order contract,...
This federal contract award is for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,001.38, is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a firm fixed-price pricing type and an ultimate completion date of August 20, 2024. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp has been awarded numerous...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3AD
    Delivery Order

This federal contract award is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,645.62, was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The award has a completion date of August 13, 2024, and utilizes a Firm Fixed Price pricing type. There is no set-aside designation for this contract.

Generated 11/11/24, 9:18 AM